Relay Therapeutics
RLAY
17.95
-0.79
-4.22%
Relay Therapeutics
US · RLAY
#2273 by market cap
Listed 2020
17.95
-0.79
-4.22%
Live - 5344 symbols - heartbeat 462s ago
· 2026-10-08 07:00
Pre-market
17.84
-0.61%
After-hours
17.95
0.00%
Overnight
17.95
0.00%
- Market cap
- 3.93B
- P/E (TTM)i
- -11.51
- P/Bi
- 4.42
- EPSi
- -1.61
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on RLAY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 4.9 percentage points.
Institutional ownership
- Held by institutions
- 123.78% -4.86pp
- Institutions
- 308 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund56.07%
VC/PE Fund35.99%
Hedge Fund16.09%
Public Company14.60%
Individual/Insider1.65%
Government Pension Fund0.26%
Sovereign Wealth Fund0.25%
Private Company0.24%
Family Office/Trust0.19%
Top holders as of 2026-06-30
SB Investment Advisers (UK) Limited
12.73% · 27.90M sh
SoftBank Group Corp.
10.00% · 21.90M sh
FMR
9.70% · 21.27M sh
Casdin Capital, LLC
7.32% · 16.04M sh
BlackRock
6.98% · 15.29M sh
Perceptive Advisors LLC
6.44% · 14.11M sh
Commodore Capital LP
5.48% · 12.00M sh
Vanguard Capital Management, LLC
4.65% · 10.19M sh
State Street Global Advisors
4.62% · 10.13M sh
T. Rowe Price Group, Inc.
4.39% · 9.62M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 33 sells
| Name | Role | Stake |
|---|---|---|
| Sanjiv Patel | Chief Executive Officer | 0.64% |
| Mark Murcko | Co-Founder | 0.45% |
| Donald Bergstrom | President of Research & Development | 0.18% |
| Alexis Borisy | Co-Founder & Independent Chairman | 0.11% |
| Brian Adams | Chief Legal Officer | 0.10% |
| Peter Rahmer | Chief Corporate Development Officer | 0.10% |
| Thomas Catinazzo | Chief Financial Officer | 0.05% |
| Douglas Ingram | Independent Director | 0.01% |
| SoftBank Group Corp. | -- | -- |
| Linda Hill | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Donald Bergstrom | President of Research & Development | Automatic Disposition | -8,530 | $18.97 |
| 2026-09-07 | Sanjiv Patel | Chief Executive Officer | Automatic Disposition | -48,199 | $18.94 |
| 2026-09-07 | Thomas Catinazzo | Chief Financial Officer | Automatic Disposition | -17,717 | $18.94 |
| 2026-08-25 | Peter Rahmer | Chief Corporate Development Officer | Automatic Disposition | -4,508 | $20.03 |
| 2026-08-24 | SoftBank Group Corp. | -- | Private Disposition | -6,000,000 | $19.40 |
| 2026-08-16 | Sanjiv Patel | Chief Executive Officer | Automatic Disposition | -48,199 | $20.33 |
| 2026-08-13 | Thomas Catinazzo | Chief Financial Officer | Automatic Disposition | -17,717 | $19.74 |
| 2026-08-03 | Sekar Kathiresan | Independent Director | Intent to Sell (Form 144) | -42,225 | $19.57 |
| 2026-07-30 | Sekar Kathiresan | Independent Director | Intent to Sell (Form 144) | -30,000 | $18.79 |
| 2026-07-27 | Donald Bergstrom | President of Research & Development | Open Market Disposition | -2,237 | $18.61 |
| 2026-07-27 | Peter Rahmer | Chief Corporate Development Officer | Open Market Disposition | -748 | $18.61 |
| 2026-07-27 | Thomas Catinazzo | Chief Financial Officer | Open Market Disposition | -1,459 | $18.61 |
| 2026-07-20 | Sekar Kathiresan | Independent Director | Intent to Sell (Form 144) | -30,000 | $19.81 |
| 2026-07-19 | Sekar Kathiresan | Independent Director | Intent to Sell (Form 144) | -66,055 | $19.58 |
| 2026-07-06 | Sanjiv Patel | Chief Executive Officer | Automatic Disposition | -48,199 | $19.58 |
| 2026-07-05 | Donald Bergstrom | President of Research & Development | Automatic Disposition | -8,660 | $18.71 |
| 2026-07-05 | Thomas Catinazzo | Chief Financial Officer | Automatic Disposition | -17,717 | $18.69 |
| 2026-06-29 | Peter Rahmer | Chief Corporate Development Officer | Other Acquisition | +3,056 | $6.95 |
| 2026-06-29 | Peter Rahmer | Chief Corporate Development Officer | Automatic Disposition | -50,000 | $19.09 |
| 2026-06-29 | Sanjiv Patel | Chief Executive Officer | Other Acquisition | +3,056 | $6.95 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:27 · For reference only, not investment advice and not tailored to your situation.